Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fasting Conditions [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and safety study evaluating BR1015-A alone and co-administered BR1015-3 and BR1015-2 under fasting conditions in essential hypertension;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• BR1015-2
• BR1015-3
• BR1015-A

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Essential Hypertension | Phase 1 | Status: NOT_YET_RECRUITING